A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
Conclusion: Our data demonstrate that HBc149 chimeric VLPs provide a valuable platform to present EBV gp350 antigens and offer a robust basis for the development of peptide-based candidate vaccines against EBV.
Source: Theranostics - Category: Molecular Biology Authors: Xiao Zhang, Bingchun Zhao, Mingmei Ding, Shuo Song, Yinfeng Kang, Yang Yu, Miao Xu, Tong Xiang, Ling Gao, Qisheng Feng, Qinjian Zhao, Mu-Sheng Zeng, Claude Krummenacher, Yi-Xin Zeng Tags: Research Paper Source Type: research
More News: Burkitt Lymphoma | Cancer & Oncology | Carcinoma | Gastric (Stomach) Cancer | Gastroenterology | Glandular Fever (infectious mononucleosis) | Hepatitis | Hepatitis B | Hepatitis Vaccine | Hodgkin's Disease | Lymphoma | Molecular Biology | Nasopharyngeal Cancer | T-cell Lymphoma | Vaccines